University of California San Francisco

Dr. Melissa H. Coleman
Melissa H. Coleman, MD

Assistant Professor of Surgery
Division of Cardiothoracic Surgery
Associate Program Director, Thoracic Surgery Residency Program
Director of UCSF School of Medicine Clinical Immersive Experiences (CIEx)

Academic Office:
500 Parnassus Ave, MUW 405, Box 0118
San Francisco, CA 94143-0118
Tel: (415) 353-8890
Email: Melissa.Coleman@ucsf.edu 
Admin: Mari.Collings@ucsf.edu 

Thoracic Surgery & Oncology Program 
1600 Divisadero St., 4th Floor, Box 1705
San Francisco, CA 94115
Tel: 415-885-3882

Biography

Dr. Melissa H. Coleman obtained her undergraduate degree in Biology at Harvard College and her medical degree at Weill Cornell Medical College. Dr. Coleman began her General Surgery Residency at Duke University Medical Center where she completed her intern and second year. From 2009 – 2011 she was a research fellow in the Thoracic Surgery Oncology Laboratory at Brigham and Women's Hospital under the direction of Dr. Raphael Bueno, Chief of the Division of Thoracic Surgery. Her research focused on the identification of estrogen-regulated genes associated with malignant pleural mesothelioma outcomes. Dr. Coleman then completed her General Surgery Residency followed by a Surgical Critical Care and Clinical Nutrition Fellowship at Brigham and Women's Hospital. She subsequently completed a fellowship in Thoracic Surgery at UCSF. Dr. Coleman was awarded the UCSF Exceptional Physician Award in her final year as a Thoracic Surgery Fellow.

After graduation, Dr. Coleman joined the faculty at UCSF. Her clinical practice includes general thoracic surgery with a focus on thoracic oncology, robotic thoracic surgery, and surgical management of hyperhidrosis. In addition to her role as a Thoracic Surgeon, she practices critical care medicine and has a focus on medical education.

In 2021, Dr. Coleman was named a John A. Watson Faculty Scholar, an honor that confers a grant from the UCSF Dean's Diversity Fund. Dr. Coleman developed the UCSF Thoracic Surgery Fellowship curriculum and is currently pursuing research focused on learning strategies in graduate medical education. She received the 2020 UCSF Thoracic Residency Program Teaching Award, earned the UCSF Haile T. Debas Academy of Medical Educators Excellence in Teaching Award 2021 and completed the UCSF Teaching Scholars Program in 2023. Dr. Coleman is also the Director of UCSF School of Medicine Clinical Immersive Experiences (CIEx) program.

Awards & Honors

Award Conferred By Date
Academy of Medical Educators Excellence in Teaching Award Haile T. Debas Academy of Medical Educators, UCSF 2021
John A. Watson Faculty Scholar, Dean’s Diversity Fund Award UCSF School of Medicine 2021
UCSF Thoracic Residency Program Teaching Award UCSF 2020
UCSF Health Exceptional Physician Award UCSF 2019

Education

Institution Degree Dept or School End Date
UCSF Cardiothoracic Surgery Fellowship 2019
Brigham and Women's Hosptial Clinical Nutrition Fellowship 2016
Brigham and Women's Hosptial Surgical Critical Care Fellowship 2015
Brigham and Women's Hospital General Surgery Residency 2014
Weill Cornell Medical School MD 2007
Harvard University AB Biology 2002

Board Certifications

American Board of Thoracic Surgery 

American Board of Surgery, Surgery

American Board of Surgery, Surgical Critical Care

Foreign Languages Spoken

English

Program Affiliations

UCSF Helen Diller Comprehensive Cancer Center

UCSF Thoracic Surgery & Oncology Program 

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 11
  1. CHEST Critical Care
    Chen JT, Mohamed AM, Coleman MH.| | UCSF Research Profile
  2. Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.
    Blakely CM, Urisman A, Gubens MA, Mulvey CK, Allen GM, Shiboski SC, Rotow JK, Chakrabarti T, Kerr DL, Aredo JV, Bacaltos B, Gee M, Tan L, Jones KD, Devine WP, Doebele RC, Aisner DL, Patil T, Schenk EL, Bivona TG, Riess JW, Coleman M, Kratz JR, Jablons DM| | PubMed
  3. Large Language Model-Based Chatbot vs Surgeon-Generated Informed Consent Documentation for Common Procedures.
    Decker H, Trang K, Ramirez J, Colley A, Pierce L, Coleman M, Bongiovanni T, Melton GB, Wick E| | PubMed
  4. I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations.
    Files DC, Matthay MA, Calfee CS, Aggarwal NR, Asare AL, Beitler JR, Berger PA, Burnham EL, Cimino G, Coleman MH, Crippa A, Discacciati A, Gandotra S, Gibbs KW, Henderson PT, Ittner CAG, Jauregui A, Khan KT, Koff JL, Lang J, LaRose M, Levitt J, Lu R, McKeehan JD, Meyer NJ, Russell DW, Thomas KW, Eklund M, Esserman LJ, Liu KD, ISPY COVID Adaptive Platform Trial Network, undefined| | PubMed
  5. Clinical trial design during and beyond the pandemic: the I-SPY COVID trial.
    I-SPY COVID Consortium| | PubMed
  6. Acute Respiratory Distress Syndrome: Ventilator Management and Rescue Therapies.
    Coleman MH, Aldrich JM| | PubMed
  7. Association of RERG Expression with Female Survival Advantage in Malignant Pleural Mesothelioma.
    De Rienzo A, Coleman MH, Yeap BY, Severson DT, Wadowski B, Gustafson CE, Jensen RV, Chirieac LR, Richards WG, Bueno R| | PubMed
  8. Tourniquet Use in a Civilian Emergency Medical Services Setting: A Descriptive Analysis of the Boston EMS Experience.
    Kue RC, Temin ES, Weiner SG, Gates J, Coleman MH, Fisher J, Dyer S| | PubMed
  9. Sequential binary gene ratio tests define a novel molecular diagnostic strategy for malignant pleural mesothelioma.
    De Rienzo A, Richards WG, Yeap BY, Coleman MH, Sugarbaker PE, Chirieac LR, Wang YE, Quackenbush J, Jensen RV, Bueno R| | PubMed
  10. Role of adjuvant chemotherapy in NSCLC (stages I to III).
    Coleman MH, Bueno R| | PubMed
  11. Laparoscopic closure of the Petersen mesenteric defect.
    Coleman MH, Awad ZT, Pomp A, Gagner M| | PubMed